{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibqkbuag6i4qurjsi575oxy52pljderhaqt6wup57s6l6ygws4z2m",
    "uri": "at://did:plc:yhmwewfk3g3hhkrw2gf4ypna/app.bsky.feed.post/3mico6hwetdx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibhns4si25xuprqvgvwzjs7dfhqenvexbiba3wef4lur6n4avbeym"
    },
    "mimeType": "image/jpeg",
    "size": 85746
  },
  "path": "/2026/03/30/tick-tock-inside-pfizers-bid-to-vaccinate-against-lyme/",
  "publishedAt": "2026-03-30T20:27:44.000Z",
  "site": "https://dissentwatch.com",
  "tags": [
    "#Column2"
  ],
  "textContent": "Pfizer & Valneva plan a 2026 Lyme vaccine. Protein-based and four-dose, it raises questions about safety, transparency, and public trust.",
  "title": "Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme"
}